In 2019, expanded criteria for hepatocellular carcinoma (HCC), known as 5‐5‐500 (size ≤5 cm, number ≤5, alpha‐fetoprotein ≤500 ng/mL), as well as Model for End‐stage Liver Disease (MELD) exception, were… Click to show full abstract
In 2019, expanded criteria for hepatocellular carcinoma (HCC), known as 5‐5‐500 (size ≤5 cm, number ≤5, alpha‐fetoprotein ≤500 ng/mL), as well as Model for End‐stage Liver Disease (MELD) exception, were implemented in Japan. In the present study, we evaluated liver transplantation indications and the Japanese allocation policy for HCC.
Keywords:
end stage;
model end;
hepatocellular carcinoma;
stage liver;
liver disease;
japan
Journal Title: Hepatology Research
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Hepatology Research
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!